The validity of clinical examination in screening of developmental dysplasia of the hip among infants aged less than six months

Dalal Ihsan  Alswari; Selwa Elias  Yacoub; Rajab Hassan Sanaan

doi:10.56056/amj.2020.116

Authors

Dalal Ihsan Alswari M.B.Ch.B. Trainee at KHCMS (Family Medicine)
Selwa Elias Yacoub Assistant Professor. M.B.Ch.B, DCM, FICMS/FM. Trainer at KHCMS /Erbil/Iraq.
Rajab Hassan Sanaan M.B.Ch.B., MSc., BFM (Netherland). Lecturer in the University of Duhok/ College of Medicine

DOI:

https://doi.org/10.56056/amj.2020.116

Keywords:

Barlow test, Developmental Dysplasia of the Hip, Galeazzi test, Ortolani test

Abstract

Background and objectives:Developmental dysplasia of the hip is a challenging condition, requiring screening for ear- ly diagnosis. This study was conducted to assess the validity of clinical screening tests of developmental dysplasia of the hip among infants aged less than 6 months.

Methods:A cross-sectional study conducted at the center of early de- tection of childhood disability, Duhok City, Iraq for the period from April 2018 to February 2019. A convenience sample of 100 infants aged less than 6 months, who were referred to orthopedic surgeon in this center were included. Three clinical examination tests were conducted followed by ultrasonography of the hip joints.

Results: Out of 100 infants, 59 (59%) were detected by ultrasonography to have Developmental Dysplasia of the Hip; 39% had unilateral and 20% bilateral ones. Barlow test was found to have the highest sensitivity, 49.15%, with a specificity of 85.37%, positive predictive value was 82.86%, and negative predictive value was 53.85%, compared to that of Ortolani test: 30.51%, 82.93%, 72.0%, and 45.33%, respectively. Galeazzi test reported to have the lowest sensitivity (8.47%), with both specificity and positive predictive value of 100%, and negative predictive value of 43.15%. Female gender was signifi- cantly associated with Developmental Dysplasia of the Hip in infants, with female to male ratio of 1.6:1.

Conclusions: Barlow test is the clinical test of the highest sensitivity and good specificity for the screening of infant Developmental Dysplasia of the Hip. Because of the high false negative results of the three clinical screening tests, further assessment with ultrasound is recommended.

Downloads

Download data is not yet available.

References

Solomon L, Warwick D, Nayagam S. Apley’s system of orthopedics and fractures, 9th edition, London, Edward Arnold. 2010.

Lussier EC, Sun YT, Chen HW, Chang TY, Chang CH. Ultrasound screening for developmental dysplasia of the hip after 4 weeks in- creases exam accuracy and decreases follow up visits. Pediatrics& Neonatology. 2018; Online version: DOI: https://doi.org/10.1016/j.ped- neo.2018.07.008.

Huang SC, Liu HC, Chen CF, Chen CL, Liu TK. Incidence of congenital dislocation of the hip in Chinese. J Orthop Surg ROC. 1998; (5):53-65.

Chang CH, Chiang YT, Lee ZL, Kuo KN. Incidence of surgery in devel- opmental dysplasia of the hip in Taiwan. J Formos Med Assoc. 2007; (106):462-6.

Moosa NK, Kumar PT, Mahmoodi SM. Incidence of developmental dysplasia of the hip in Dubai. Saudi Med J. 2009; 30(7):952-5.

Woolacott NF, Puhan MA, Steurer J, Kleijnen J. Ultrasonography in screening for developmental dysplasia of the hip in newborns: system- atic review. BMJ. 2005;330(7505):1413.

Kishore KR, Shah P, An R, Rajan R. Diagnosing Developmental Dysplasia of Hip in Newborns Using Clinical Screen and Ultrasound of Hips- An Indian Experience. J Trop Pediatr. 2016;62(3):241-5.

White KK, Bouchard M, Goldberg MJ. Common Neonatal Orthopedic Conditions. In: Gleason CA, Juul SE, editors. Avery’s Diseases of the Newborn (Tenth Edition). Philadelphia: 2018. p. 1438- 49. e3.

Akgün S, Bakar C, Tuncay C. Is clinical examination reliable in diagnosis of developmental dysplasia of the hip? Gazi Med J. 2008;19(2):56- 59.

Souza BGSE, Melo TE, Resende TM, Silva RC, Cruz SA, Oliveira VM. Developmental dysplasia of the hip: do the responsible for screening know what to do? Acta Ortopédica Brasileira. 2016;24: 312-7.

Predrag G, Rade T, Milan G. Reliability and validity of clinical and ultrasound examinations of developmental hip dysplasia. Acta Medica Medianae. 2011;50(1):26-31.

Jackson JC, Runge MM, Nye NS. Common questions about devel- opmental dysplasia of the hip. Am Fam Physician. 2014;90(12):843-50.

Mace J, Paton RW. Neonatal clinical screening of the hip in the diagnosis of developmental dysplasia of the hip: a 15-year prospective longitudinal observational study. The bone & joint journal. 2015;97- b(2):265-9.

Sewell MD, Eastwood DM. Screening and treatment in developmental dysplasia of the hip-where do we go from here? Int Orthop. 2011;35(9):1359-67.

Arti H, Mehdinasab SA, Arti S. Comparing results of clinical versus ultrasonographic examination in developmental dysplasia of hip. J Res Med Sci. 2013;18(12):1051-5.

Rosendahl K, Markestad T, Lie RT. Ultrasound screening for develop- mental dysplasia of the hip in the neonate: the effect on treatment rate and prevalence of late cases. Pediatrics. 1994;94(1):47-52.

Brian A, Lee S. Evaluation and Referral for Developmental Dysplasia of the Hip in Infants. Pediatrics. 2016;138(6):e20163107.

Thaler M, Biedermann R, Lair J, Krismer M, Landauer F. Costeffectiveness of universal ultrasound screening compared with clinical examination alone in the diagnosis and treatment of neonatal hip dys- plasia in Austria. J Bone Joint Surg Br. 2011;93(8):1126-30.

Sezer C, Unlu S, Demirkale I, Altay M, Kapicioglu S, Bozkurt M. Prevalence of developmental dysplasia of the hip in preterm infants with maternal risk factors. J Child Orthop. 2013;7(4):257-61.

Källén B. Risk Factors for Developmental Dysplasia of the Hip in the Newborn. Data from the Swedish Medical Birth Register. Clinics Mother Child Health. 2014.11(1);1000153.